Teva willing to post $500 million bond in Copaxone case
April 17, 2014 at 15:18 PM EDT
WASHINGTON, April 17 (Reuters) - Teva Pharmaceutical Industries Ltd on Thursday told the U.S. Supreme Court that it is willing to post up to a $500 million bond in return for a decision suspending a lower court ruling that would allow generic competitors to go on the market as soon as next month.